D
Zevra Therapeutics, Inc. ZVRA
$8.31 $0.374.66%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -105.51M -89.66M -66.81M -49.45M -46.05M
Total Depreciation and Amortization 6.39M 5.53M 3.97M 2.49M 1.01M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 36.10M 18.93M 3.15M 2.57M 5.63M
Change in Net Operating Assets -6.64M -4.37M 3.63M -1.26M 5.88M
Cash from Operations -69.67M -69.57M -56.06M -45.66M -33.54M
Capital Expenditure -- -72.00K -244.00K -267.00K -296.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -30.40M -30.40M -30.40M -30.40M
Divestitures -- -- -- -- --
Other Investing Activities -22.16M 24.37M 11.44M 45.63M 13.31M
Cash from Investing -22.16M -6.11M -19.21M 14.96M -17.39M
Total Debt Issued 60.07M 63.70M 89.70M 30.77M 43.69M
Total Debt Repaid -43.13M -47.86M -47.66M -4.88M -18.10M
Issuance of Common Stock 67.26M 72.57M 7.86M 7.54M 6.32M
Repurchase of Common Stock -- 0.00 0.00 0.00 -3.45M
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -2.09M -2.09M -2.09M -- --
Cash from Financing 82.11M 86.32M 47.81M 33.43M 28.46M
Foreign Exchange rate Adjustments 454.00K 132.00K 521.00K -66.00K 44.00K
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -9.26M 10.77M -26.94M 2.67M -22.42M
Weiss Ratings